Recent Headlines
Eurofarma Synapsis Receives Registrations Until June 21
Sustainable entrepreneurship platform in Latin America in partnership with Endeavor, encourages innovation in health area. - May 09, 2019 - Eurofarma
Reuters to Make Documentary on Paras Biopharmaceuticals Finland Oy – Innovations in Biologics: Insights of a Leading Expert
Paras Biopharmaceuticals Finland Oy is proud to announce that Reuters.com / Reuters Plus has selected the Finland-based company, working on biologics manufacturing & innovations in the healthcare segment as a valued contributor to the future of healthcare solutions. The documentary is part of... - May 07, 2019 - Paras Biopharmaceuticals Finland Oy
NanoCellect Biomedical Begins Distribution to Europe
NanoCellect Biomedical Inc., a leader in the development and manufacture of microfluidic cell sorting solutions for cell-based assays, today announced an exclusive distribution agreement with Basel, Switzerland-based Bucher Biotec AG. The agreement covers sales in Switzerland of NanoCellect’s... - May 01, 2019 - NanoCellect
MD Stem Cells New Alzheimer’s Treatment Shows Early Benefits
Initial memory improvements following ACIST stem cells may hold promise for ALZ. - April 24, 2019 - MD Stem Cells
Standigm Raises US $11.5 Million in Series B Round Funding to Advance Its AI-Powered Drug Pipelines Toward License-Out
Standigm, an AI-powered drug discovery company, has raised $11.5 million in a Series B funding round. The funds will be used to scale the AI technology platforms and advance its drug discovery pipelines for untreatable diseases. - March 29, 2019 - Standigm
Are Antioxidants the Solution to Burning and Itchy Eyes?
A recently published study in The Ocular Surface journal authored by Experimentica Ltd. in collaboration with researchers from Loyola University Chicago and the University of Missouri – Kansas City suggests that a topical antioxidant formulation can improve the pathological signs associated with dry-eye disease. - March 26, 2019 - Experimentica Ltd
Daryn Henry Joins Arteric as Creative Director
Veteran Digital Communicator Brings Decades of Award-Winning Experience to Boundary-Pushing Agency. - March 15, 2019 - Arteric
Arteric Explores Current Uses of Artificial Intelligence and Machine Learning to Accelerate Digital NPP Engagement for Biotechnology and OTC Brands
Arteric Shares Case Studies with Life Science Leaders, Illustrating Methods to Increase the Relevance and Authority of Brand Content. - March 14, 2019 - Arteric
Arteric Guides Healthcare Marketing Leaders on Practical Applications of Artificial Intelligence (AI) to Uncover Unmet Customer Needs
Two Case Studies Illustrate the Impact of AI on Accelerating Business, and the Insights That Result. - March 04, 2019 - Arteric
Standigm Launches Artificial Intelligence-Driven Drug Discovery Service at 2019 BIO-Asia International Conference in Tokyo, Japan
Standigm, a company using the advanced AI technology to drug discovery, launched the customized early drug discovery and target study service, "Standigm Insight®," at 2019 BIO-Asia International Conference in Tokyo, Japan. Standigm Insight® provides AI-driven new indication prediction and novel target analysis service for customer’s in-house products. - March 04, 2019 - Standigm
Sanyal Biotechnology Hires IQVIA / BuzzeoPDMA DEA Compliance Group
Sanyal Bio has expanded into pre-clinical and clinical contract research on cannabinoids. Sanyal Bio currently holds a DEA Schedule 1 Import License for Cannabis Extracts and THC, with applications pending for Research, Analytical and Manufacturing licenses. IQVIA's DEA Compliance group is well-respected for their expertise and Sanyal Bio looks forward to working with this reputable group going forward. - February 13, 2019 - Sanyal Biotechnology
Plant Extract Can Help Prevent Cancer Recurrence says the Beljanski Foundation
Rauwolfia Vomitoria, a Natural Plant Extract, Inhibits Cancer Stem Cells - February 08, 2019 - The Beljanski Foundation
Milestone in Cancer Stem Cell Research by Beljanski Foundation
Research Shows Pao Pereira, a Natural Plant Extract, Inhibits Cancer Stem Cells. - February 08, 2019 - The Beljanski Foundation
Paras Biopharmaceuticals Finland Oy Announces Successful Development of Biologically Active Romiplostim (N-Plate® Biosimilar) Production Technology
Paras Biopharmaceuticals Finland Oy today announced the achievement of a major milestone – the successful development of biologically active Romiplostim (N-Plate® biosimilar) production technology. Romiplostim has been produced with a proprietary and innovative continuous manufacturing... - January 31, 2019 - Paras Biopharmaceuticals Finland Oy
Hans Kaspersetz Joins Digital Pharma West Advisory Board
Digital Marketing Thought Leader to Help Craft Agenda for Leading Healthcare Marketing Conference. - January 25, 2019 - Arteric
Global OrthoBiologic Expands Its Operation Under the Name Global REGENERATIVE Group (GRG)
Global OrthoBiologic has announced today that it will expand its operation under the name Global REGENERATIVE Group (GRG) with headquarters to remain in Miami, Florida (globalregenerative.group) and will consist of 4 divisions, which will operate independently – Trade, Academy, Care and Finance. - January 16, 2019 - Global Regenerative Group
Bioquark Inc. and Ectocrine Technologies LLC to Collaborate on Mosquito-Derived Health Product Development
The common mosquito, while being responsible for up to a million human deaths each year, may paradoxically also hold biochemical secrets to cure diseases that effect hundreds of millions of people around the globe. - January 12, 2019 - Bioquark Inc.
Kannaki Ramamoorthy Joins Arteric as Quality Assurance Manager
Software-Development Veteran Leads Team Renowned for Impeccable Standards. - December 21, 2018 - Arteric
Clinical Safety and Efficacy Data of DSP-Visulex Published in Current Eye Research
Aciont Inc. announced today that data from the clinical study of the DSP-Visulex technology is published online ahead of print in Current Eye Research. Reference: Papangkorn K, Truett KR, Vitale AT, Jhaveri C, Scales DK, Foster CS, Montieth A, Higuchi JW, Brar B, Higuchi WI. Novel dexamethasone sodium phosphate treatment (DSP-Visulex) for noninfectious anterior uveitis: a randomized phase I/II clinical trial. Current Eye Research. - December 06, 2018 - Aciont Inc.
Silas Kim Joins Arteric as Talent Acquisition Manager
Fills talent pool at rapidly growing healthcare digital marketing agency - November 30, 2018 - Arteric
CrystalGenomics Signs Export Agreement with PharmArtis for Acelex in Russia
CrystalGenomics, Inc. announced today that they have signed an Export Agreement with PharmArtis International for the commercialization of Acelex® (polmacoxib) in Russia. Based on the terms of the agreement, CrystalGenomics will supply finished product of Acelex to PharmArtis and PharmArtis... - November 24, 2018 - CrystalGenomics, Inc.
Don Rodriguez Joins Arteric as Director, Analytics & Paid Search
Data Maven Brings a History of Double-Digit Growth in Client Revenue to a Growing Strategy, Analytics and Media Team. - November 16, 2018 - Arteric
Arteric to Present on Practical Applications of Artificial Intelligence (AI) in Healthcare Marketing
Two Case Studies Illustrate the Impact of AI on Accelerating Business, and the Insights That Result - November 07, 2018 - Arteric
Standigm Launches Artificial Intelligence-Driven Lead Optimization Service at BIO-Europe 2018 in Copenhagen, Denmark
Standigm, a company using the advanced AI technology to drug discovery, launched the customized lead optimization service, "Standigm BEST®," at BIO-Europe 2018 in Copenhagen, Denmark. Standigm BEST® provides AI-driven lead optimization and can also be utilized for fast-follow hit identification or patent fencing strategy. One-to-one meetings have been scheduled with leading pharmaceutical companies, indicating their interest in Standigm BEST®. - November 05, 2018 - Standigm
VIRUN® and Algarithm™ to Debut O3Omega™ NOT Peanut Butter and Jelly Sandwich Multi-serving Smoothies in Booth 1637 at Supply Side West Expo, Las Vegas on November 8 and 9
Virun® and Algarithm™ offer chill vibe at otherwise chaotic Supplyside West, serve up adult beverages enhanced with DHA and flavored like deserts, to debut new vegan O3Smoothies flavor, NOT Peanut Butter and Jelly. - November 02, 2018 - VIRUN
AdvantaPure(R) Introduces AdvantaSil(TM) Ultra Low Temperature Silicone Tubing That’s Engineered for Temperatures as Low as -112°C
New AdvantaSil Ultra Low Temperature Silicone Tubing is designed to aid pharmaceutical and biopharm manufacturers with protecting their high-value cell and drug products. The platinum-cured tubing is engineered for Single-Use applications involving cold storage and transport. It’s the first commercially-available tubing engineered for flexibility and crush resistance upon removal from a minus 86 degrees C freezer. A video on AdvantaPure’s website shows the test procedures and results. - November 01, 2018 - AdvantaPure
Arteric to Present on Practical Applications of Artificial Intelligence (AI) in Healthcare Marketing at Life Science Leader Summit
Two Case Studies Illustrate the Impact of AI on Accelerating Business, and the Insights That Result. - October 26, 2018 - Arteric
Monica D’Amico Joins Arteric as an Account Supervisor
Broad Digital Experience and Deep Client Commitment Augment Stellar Account Team. - October 26, 2018 - Arteric
Arteric.com Captures Five More Website Design Awards
Total Number of Awards Reaches 13. - October 12, 2018 - Arteric
Columbia University Announces Formation of CuRAGE Therapeutics; Lead Candidate CR-3 Monoclonal Antibody Being Developed for the Treatment of Peripheral Artery Disease
Company to Present at NYC Invitation-Only VC Event Oct. 30 - October 06, 2018 - CuRAGE Therapeutics
Arteric Sponsors Digital Pharma East
Digital Marketing Agency Continues Support of Major Healthcare Conference - October 05, 2018 - Arteric
Hans Kaspersetz to Moderate Panel at Healthcare Marketing Summit
Veteran Digital Marketing Strategist Guides Discussion on Personalization Strategies - September 21, 2018 - Arteric
Spherium’s Cyclatop (SP14019), Safe and Efficacious for the Treatment of Atopic Dermatitis in Adults and Infants
The results of the clinical trial Cyclatop (NCT02865356) to investigate the safety, tolerability, pharmacokinetics and efficacy of SP14019 (Cyclosporine A 5% topical spray) across all group ages, for the treatment of mild to moderate atopic dermatitis, were presented today at the EADV Congress in Paris. SP14019 showed excellent safety and acceptability profile, clinically relevant and statistically significant efficacy with respect to placebo and very low systemic exposure to Cyclosporine A. - September 15, 2018 - Spherium Biomed
Experimentica Ltd. Presents at the ISER in Belfast, Northern Ireland - XXIII Biennial Meeting of the International Society for Eye Research September 9-13, 2018 | Belfast
The XXXIII Biennial Meeting of the International Society of Eye Research takes place this year from September 9-13th in Belfast, Northern Ireland, UK. Dr Jenni J. Hakkarainen – Acting COO of Experimentica Ltd. will present an oral presentation on a metalloporphyrin superoxide dismutase mimetic and the dry-eye disease. Dr Simon Kaja – CSO of Experimentica Ltd. will chair a session and present on cellular mechanisms of reactive astrocytosis and opportunities for glioprotection. - September 08, 2018 - Experimentica Ltd
CrystalGenomics Signs Export Agreement with Apsen Farmacêutica for Acelex in Brazil
CrystalGenomics, Inc. announced today that they have signed an Export Agreement with Apsen Farmacêutica for the commercialization of Acelex® (polmacoxib) in Brazil. Under the terms of the agreement, Apsen will secure exclusive rights for the Brazilian market to sell and market Acelex... - September 05, 2018 - CrystalGenomics, Inc.
Arteric Certified as a Veeva CLM Service Partner
Expands Content Development and Management Options for Healthcare Marketers - August 31, 2018 - Arteric
Trial Runners Strengthens Its Leadership Team
Trial Runners is pleased to announce additions to their executive team as well as their leadership team as a result of a fast-paced growth year. - August 17, 2018 - Trial Runners
Cayman Partners with LIPID MAPS® to Support Continued Development of Key Lipidomic Research Resources
Cayman has increased its financial support of the LIPID MAPS® Lipidomics Gateway. The newly launched LIPID MAPS® website (June 2018) provides easy access to free tools and resources, including a searchable lipid structure database (with over 43,000 entries), mass spectrometry spectra prediction tools, lipid structure drawing tools, experimental protocols, systems biology pathway maps, statistical analysis tools, and a curated lipid standards database. - July 21, 2018 - Cayman Chemical Company
New Assay for Immunology Research Quantifies cGAS-Produced 2’3’-cGAMP in Cells
Sensitive and direct measurement of cGAMP levels in cell lysates is now possible with Cayman’s much-anticipated 2’3’-cGAMP ELISA Kit. Developed by Cayman scientists, in conjunction with expert nucleotide scientists at Biolog Life Science Institute in Germany, this competitive... - July 20, 2018 - Cayman Chemical Company
Medical Marketing and Media Names Arteric an Agency to Watch
Healthcare Digital Marketing Agency Recognized for Award-Winning, Ground-Breaking Work. - July 17, 2018 - Arteric
AdvantaPure® Introduces New Case Studies on Tubing, Closures and Molded Assemblies; Each Study Describes Processing Problems, Customer Goals, and Product Solutions
Three new case studies from AdvantaPure highlight fluid transfer challenges in the biopharm and pharmaceutical industries. One study explores leak-proof container systems coupled with the goal of foam reduction. Another focuses on Single-Use molded tubing assemblies in a final fill application. The third examines how a customer decided between movable totes and two styles of clean room wall pass-through systems. - July 14, 2018 - AdvantaPure
NuvOx Pharma Receives $2M SBIR Grant for Pancreatic Cancer Diagnostic Development
Evan Unger, MD, President and CEO of NuvOx Pharma, announced that NuvOx has received a $2M Phase II Small Business Innovation Research (SBIR) grant from the National Cancer Institute to fund the development of a new strategy to detect pancreatic cancer. The grant, 2R44CA203090-02, entitled... - July 14, 2018 - NuvOx Therapeutics
Arteric.com Continues to Garner Accolades
4 Communicator Awards Raise Total to 8 Trophies From 3 Competitions - July 10, 2018 - Arteric
AdvantaPure® Completes Full BPOG Extractables Testing of Several Silicone and TPE Tubing Products; Provides Drug Manufacturers with Extensive Test Results for Comparison
Tubing manufacturer AdvantaPure announces the completion of BPOG testing on three of its tubing lines used for biopharm and pharmaceutical applications. Two styles of silicone tubing – standard and high pressure – and the company’s weldable and sealable TPE tubing now offer full BPOG test results for extractable compounds. Tests were performed by a fully-accredited, third-party test lab using a variety of analytical techniques. Results are available upon request. - June 14, 2018 - AdvantaPure
Arteric to Present on Practical Applications of Artificial Intelligence (AI) in Healthcare Marketing at Digital Pharma West
Two Case Studies Illustrate the Impact of AI on Accelerating Business, and the Insights That Result. - June 08, 2018 - Arteric
Arteric.com Named Best Marketing Website and Best Professional Services Website
Latest Awards Follow Wins for Mobile Website Design. - June 06, 2018 - Arteric
MoBiTec GmbH Teams Up with ABP Biosciences, US, to Offer Superior Fluorophores at Reasonable Prices
ABP Biosciences invents, develops, and markets innovative products and technologies to scientists engaged in life sciences research, diagnostic R&D, and drug discovery. ABP specializes in the area of fluorescence labeling and detection technologies. - June 06, 2018 - MoBiTec GmbH
AdvantaPure(R) Contributes to Newly-Released Forecasting and Supply Planning Guide from BPOG; Combined Effort Aims to Improve Forecasting and Demand Planning
BPOG, the BioPhorum Operations Group, recently developed a best practices guide on forecasting and demand planning involving the biopharmaceutical industry. The guide, a collaborative effort involving biomanufacturers and suppliers, is available from BPOG’s website. It aims to help manufacturers and their vendors improve understanding and communication regarding each other’s needs. A self-assessment tool for measuring companies’ current planning processes is also available from the site. - June 01, 2018 - AdvantaPure
Virun® NutraBIOsciences® and Algarithm™ Ingredients Launch O3Omega™ Smoothies in Canada; Patent for Viruns' Spray-Dry Technology Receives Notice of Allowance in U.S.
Virun® NutraBIOsciences® and Algarithm™ Ingredients Announce O3Omega™ Smoothies Line Picked Up by Canadian Retail Giant Co-op so People Can Enjoy Plant-Based Omega 3s Every Day, the Easy Way, Notice of Allowance for Patent Covering Spray-Dried Powders Containing Non-Polar Compounds. - May 10, 2018 - VIRUN
Artificial Intelligence: Hype or Help for Healthcare Marketers?
Arteric's President Shares How AI Detects Important Signals of Audience Behavior - May 04, 2018 - Arteric